Skip to main content
iwCLL 2025 Main banner
Final Program


Save The Date

Faculty

  1. Home
  2. Faculty

Faculty

 

Names Organization City State Country
  • A
  • SA
    Acharya, Sunil (PhD)
    Principal Institute Research Scientist, Rezvani Lab
    The University of Texas MD Anderson Cancer Center
    Houston, Texas, United States
  • Ahn, Inhye E. (MD)
    Assistant Professor
    Dana-Farber Cancer Institute
    Boston, Massachusetts, United States
  • Al-Sawaf, Othman (MD)
    Faculty of Medicine
    Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital
    Cologne, Germany
  • B
  • MB
    Bertilaccio, Maria Teresa Sabrina. (PhD)
    Assistant Professor
    The University of Texas MD Anderson Cancer Center
    Houston, Texas, United States
  • FB
    Bosch, Francesc (MD, PhD)
    Head, Dept of Hematology; Director, Experimental Hematology (VHIO); Professor
    Universtitat Autonoma Barcelona, Hospital Universitari Vall d'Hebron
    Barcelona, Catalonia, Spain
  • Brown, Jennifer R. (MD, PhD)
    Director, CLL Center, and Institute Physician; Worthington Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
    Dana-Farber Cancer Institute, Harvard Medical School
    Boston, Massachusetts, United States
  • TB
    Bruno, Tullia (PhD)
    Assistant Professor
    The University of Pittsburgh Hillman Cancer Center
    Pittsburgh, Pennsylvania, United States
  • C
  • Chen, Shih-Shih (PhD)
    Assistant Professor
    The Feinstein Institutes for Medical Research
    Manhasset, New York, United States
  • NC
    Chiorazzi, Nicholas (MD)
    Professor
    The Feinstein Institutes for Medical Research, Northwell Health System
    New York, New York, United States
  • D
  • FD
    Damm, Frederik (MD)
    Clonal Hematopoiesis & Lymphoma-associated Mutations in Hematopoietic Progenitors in CLL & B-Cell Non-Hodgkin Lymphoma
    Dept of Hematology, Oncology, & Cancer Immunology, Charité - Universitätsmedizin Berlin
    Berlin, Germany
  • Danilov, Alexey V. (MD, PhD)
    Professor
    Department of Hematology and Transplantation, City of Hope National Medical Center
    Duarte, California, United States
  • Davids, Matthew S. (MD, MMSc)
    Director, Clinical Research, Division of Lymphoma; Associate Professor of Medicine
    Dana-Farber Cancer Institute
    Boston, Massachusetts, United States
  • Deaglio, Silvia (MD, PhD)
    Professor of Medical Genetics
    University of Turin
    Turin, Italy
  • E
  • Eichhorst, Barbara (MD)
    Associate Professor, Consultant Hematologist
    Department I of Internal Medicine, University Hospital of Cologne
    Cologne, Germany
  • F
  • MF
    Fürstenau, Moritz (MD)
    Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne
    Cologne, Germany
  • AF
    Ferrajoli, Alessandra (MD)
    Professor
    The University of Texas MD Anderson Cancer Center
    Houston, Texas, United States
  • G
  • RG
    Gabus, Raúl (MD)
    Former Head of Hematology and SCT Department
    Hospital Maciel, ASSE
    Montevideo, Montevideo, Uruguay
  • Gaidano, Gianluca (MD, PhD)
    Professor of Hematology
    University of Eastern Piedmont, Maggiore Charity Hospital
    Novara, Italy
  • Gandhi, Varsha (PhD)
    Professor
    MD Anderson Cancer Center
    Houston, Texas, United States
  • SG
    Geyer, Susan (PhD)
    Professor of Biostatistics
    Mayo Clinic
    Rochester, Minnesota, United States
  • EG
    Ghia, Emanuela M. (PhD)
    Scientific Director of Biobanking and Correlative Sciences; Project Scientist
    Center for Novel Therapeutics; University of California, San Diego
    La Jolla, California, United States
  • Ghia, Paolo (MD, PhD)
    Professor of Medical Oncology
    Università Vita Salute and IRCCS Ospedale San Raffaele
    Milano, Lombardia, Italy
  • H
  • Hallek, Michael (MD, PhD)
    Principal Investigator, Director of Department I of Internal Medicine
    German CLL Study Group, University Hospital of Cologne
    Cologne, Germany
  • TH
    Hartmann, Tanja (PhD)
    Professor, Group Leader
    Medical Center University Freiburg, Head Research and Clinical Research Coordination, Comprehensive Cancer Center Freiburg
    Freiburg, Germany
  • IH
    Hus, Iwona (MD, PhD)
    Professor
    National Medical Institute of the Ministry of the Interior and Administration
    Warsaw, Poland
  • I
  • EI
    Iskierka-Jażdżewska, Elżbieta (MD, PhD)
    Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital in Lodz, Poland
    Łódź, Lodzkie, Poland
  • J
  • Jain, Nitin (MD)
    Professor
    The University of Texas MD Anderson Cancer Center
    Houston, Texas, United States
  • KJ
    Jamroziak, Krzysztof (MD, PhD)
    Professor, Deputy Head of the Department of Hematology
    Medical University of Warsaw
    Warsaw, Poland
  • PJ
    Jasani, Parag D. (MBBS, FRCP, FRCPath)
    Consultant Hematologist
    Royal Free London NHS Trust and University College London NHS Trust
    London, England
  • K
  • Kater, Arnon P. (MD, PhD)
    Vice Chair, Hematologist & Principal Scientist
    Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, and HOVON
    Amsterdam, Noord-Holland, Netherlands
  • Kipps, Thomas J. (MD, PhD)
    Distinguished Professor of Medicine, Co-Director, Hematology Malignancy Program; Director, Center for Novel Therapies; Evelyn and Edwin Tasch Chair in Cancer Research
    UC San Diego, Moores Cancer Center
    San Diego, California, United States
  • Koffman, Brian (MD)
    Co-Founder, Executive Vice President, Chief Medical Officer
    CLL Society, Inc., Chula Vista
    Claremont, California, United States
  • L
  • AL
    Langerak, Anton W.
    Professor
    Erasmus MC, Rotterdam
    Rotterdam, Zuid-Holland, Netherlands
  • M
  • IM
    Martin-Subero, Inaki (PhD)
    ICREA Research Professor
    Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
    Barcelona, Spain
  • FM
    Meier-Abt, Fabienne Christine (MD, PhD)
    Institute of Medical Genetics, University of Zurich; Department of Medical Oncology and Hematology, University Hospital Zurich
    Zurich, Switzerland
  • Melenhorst, J. Joseph (PhD)
    Professor; Professor of Biomedical Engineering; Director, Cell Therapy and Immuno-Eingineering Program (CTIP)
    Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland Clinic
    Cleveland, Ohio, United States
  • Moussay, Etienne (PhD)
    Group Leader, Tumor Stroma Interactions
    Luxembourg Institute of Health
    Luxembourg, Luxembourg
  • Mraz, Marek (MD, PhD)
    PI
    CEITEC Masaryk University and University Hospital Brno
    Brno, Czech Republic
  • MM
    Müschen, Markus (MD-PhD)
    Arthur H. and Isabel Bunker Professor of Hematology, Director Center of Molecular and Cellular Oncology
    Yale University
    New Haven, Connecticut, United States
  • NM
    Muthusamy, Natarajan (Raj) (DVM, PhD)
    Professor of Medicine
    The Ohio State University
    Columbus, Ohio, United States
  • N
  • Nadeu, Ferran (PhD)
    Postdoctoral Fellow
    Institut d'Investigacions Biomèdiques August Pi i Sunyer
    Barcelona, Catalonia, Spain
  • Niemann, Carsten U. (MD, PhD)
    Associate Professor
    Rigshospitalet, Copenhagen University Hospital
    Copenhagen, Hovedstaden, Denmark
  • O
  • O'Brien, Susan M. (MD)
    Professor, Division of Hematology/Oncology
    Chao Family Comprehensive Cancer Center, University of California
    Irvine, California, United States
  • Opat, Stephen S. (MBBS)
    Director, Cancer Services
    Monash University
    Caulfield South, Victoria, Australia
  • P
  • Parry, Erin M. (MD, PhD)
    Physician, Assistant Professor of Medicine
    Dana-Farber Cancer Institute, Harvard Medical School
    Boston, Massachusetts, United States
  • Pospisilova, Sarka (PhD)
    Professor,
    Masaryk University and University Hospital Brno
    Brno, Czech Republic
  • BP
    Pula, Bartosz (MD, PhD)
    Hematologist
    Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital
    Łódź, Lodzkie, Poland
  • R
  • Ramsay, Alan G. (PhD)
    Reader (Associate Professor) in Lymphoma Biology
    Lymphoma Immunology Group, Kings College London
    London, England, United Kingdom
  • Robak, Tadeusz (MD, PhD)
    Professor of Hematology; Head, Department of General Hematology & Internal Medicine
    Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital
    Łódź, Lodzkie, Poland
  • Roeker, Lindsey E. (MD)
    Senior Associate Consultant
    Division of Hematology, Mayo Clinic
    Rochester, Minnesota, United States
  • Rogers, Kerry A. (MD)
    Associate Professor
    Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center
    Columbus, Ohio, United States
  • Rossi, Davide (MD, PhD)
    Prof. Dr. med.
    Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI)
    Bellinzona, Switzerland
  • ER
    Rotbain, Emelie Curovic. (MD, PhD)
    Postdoc
    Rigshospitalet, Copenhagen University Hospital
    Copenhagen, Denmark
  • S
  • CS
    Scheepers, Catherina (MS)
    Region Head
    The Max Foundation
    Pretoria, South Africa
  • Schuh, Anna (MD, PhD)
    Professor
    Churchill Hospital, Oxford University
    Oxford, England, United Kingdom
  • Seiffert, Martina (PhD)
    Group Leader, Division of Molecular Genetics
    German Cancer Research Center
    Heidelberg, Germany
  • JS
    Seymour, John (MBBS, PhD, FRACP)
    Director, Department of Haematology
    Peter MacCallum Cancer Centre & Royal Melbourne Hospital
    Melbourne, Victoria, Australia
  • Shadman, Mazyar (MD, MPH)
    Professor
    Fred Hutchinson Cancer Center
    Seattle, Washington, United States
  • HS
    Simon-Molas, Helga (PhD)
    Postdoctoral Researcher
    Amsterdam University Medical Centers
    Amsterdam, Netherlands
  • SS
    Slager, Susan (PhD)
    Professor
    Department of Quantitative Health Sciences, Division of Hematology, Mayo Clinic
    Rochester, Minnesota, United States
  • Soumerai, Jacob (MD)
    Assistant Professor of Medicine
    Center for Lymphoma, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Boston, Massachusetts, United States
  • Stamatopoulos, Kostas (MD, PhD)
    Principal Investigator
    Institute of Applied Biosciences, Centre for Research and Technology Hellas
    Thessaloniki, Thessaloniki, Greece
  • Stephens, Deborah M. (DO)
    Associate Professor; Director of the CLL and Richter Transformation Program
    Lineberger Comprehensive Cancer Center, University of North Carolina
    Chapel Hill, North Carolina, United States
  • Stilgenbauer, Stephan (MD)
    Professor of Medicine, Medical Director
    Division of CLL, Internal Medicine III, Ulm University
    Ulm, Baden-Wurttemberg, Germany
  • T
  • Tadmor, Tamar (MD)
    Associate Professor, Head of Hematology Unit
    Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine
    Haifa, Israel
  • Tausch, Eugen (MD)
    Treating Physician and Research Fellow
    Division of CLL, Department of Internal Medicine III, University Hospital Ulm
    Ulm, Germany
  • ten Hacken, Elisa (PhD)
    Assistant Professor
    Weill Cornell Medicine
    New York, New York, United States
  • Thompson, Philip (MB, BS (Hons))
    Consultant Haematologist
    Peter MacCallum Cancer Centre & Royal Melbourne Hospital; The Sir Peter MaCallum Department of Clinical Oncology, University of Melbourne
    Melbourne, Victoria, Australia
  • W
  • WW
    Wierda, William G. G. (MD, PhD)
    Professor of Medicine
    The University of Texas MD Anderson Cancer Center
    Houston, Texas, United States
  • Woyach, Jennifer A. (MD)
    Professor of Medicine
    Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center
    Columbus, Ohio, United States
  • Wu, Catherine (MD)
    Professor of Medicine
    Dana-Farber Cancer Institute, Harvard Medical School
    Boston, Massachusetts, United States
  • Y
  • Yost, Andrielle (MPA)
    Associate Director, Public Sector Engagement
    The Max Foundation
    Philadelphia, Pennsylvania, United States
  • Z
  • Zenz, Thorsten (MD)
    Professor
    University of Zurich
    Zurich, Zurich, Switzerland